Initial versus recent outcomes with a non-risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT)

被引:0
|
作者
Duran, I. [1 ]
Sturgeon, J. F. [1 ]
Jewett, M. A. [1 ]
Anson-Cartwright, L. [1 ]
Berthold, D. R. [1 ]
Kakiashvili, D. [1 ]
Warde, P. R. [1 ]
Alison, R. E. [1 ]
Pond, G. R. [1 ]
Moore, M. J. [1 ]
机构
[1] Princess Margaret Hosp, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5021
引用
收藏
页数:1
相关论文
共 50 条
  • [31] CHEMOTHERAPY FOR NON-SEMINOMATOUS GERM-CELL TUMORS
    WILKINSON, PM
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 : 43 - 47
  • [32] THE EFFECT OF SOCIODEMOGRAPHIC FACTORS ON THE MANAGEMENT OF STAGE I NON-SEMINOMATOUS GERM CELL TESTICULAR TUMORS
    Patel, Anand
    Kim, Simon
    Maurice, Matthew
    Kiechle, John
    Zhu, Hui
    Abouassaly, Robert
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1057 - E1057
  • [33] Immunohistologic profile of spindle cell elements in non-seminomatous germ cell tumors (NSGCT): Histogenetic implications.
    Shah, VI
    Amin, MB
    Linden, MD
    Zarbo, RJ
    MODERN PATHOLOGY, 1998, 11 (01) : 96A - 96A
  • [34] Oxaliplatin in non-seminomatous germ-cell tumors
    Fizazi, K
    Culine, S
    Chen, I
    ANNALS OF ONCOLOGY, 2004, 15 (08) : 1295 - 1295
  • [35] Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
    de Bono, J. S.
    Paul, J.
    Simpson, A.
    Anthoney, A.
    Kirk, D.
    Underwood, M.
    Graham, J.
    Kaye, S. B.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 426 - 430
  • [36] Outcomes of patients with stage I non-seminomatous germ cell tumours (NSGCT) of the testis at a tertiary care cancer centre in a low resource country: Is strict surveillance necessary?
    Tongaonkar, Arnav
    Joshi, Amit
    Menon, Nandini
    Noronha, Vanita
    Bakshi, Ganesh
    Murthy, Vedang
    Menon, Santosh
    Sable, Nilesh
    Krishnatry, Rahul
    Popat, Palak
    Pal, Mahendra
    Prakash, Gagan
    Prabhash, Kumar
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 81 - 82
  • [38] A differential gene expression signature identifies a population of stage I testicular non-seminomatous germ cell tumours (NSGCT) at high risk of relapse
    Galvez-Carvajal, L.
    Sanchez-Munoz, A.
    Alvarez, M.
    Alba Linero, E.
    del Rey, M.
    Garrido, A.
    Santoja, A.
    Moya, A.
    Montes, J.
    Chica-Parrado, M. R.
    Saez, M. I.
    Aparicio, J.
    Gonzalez-Billalabeitia, E.
    Terrasa Pons, J.
    Mendez, M. J.
    Luengo, M.
    Garcia del Muro, J.
    Pascual, J.
    Alba, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S601 - S602
  • [39] Surveillance for Boys with Localized Testicular Non-Seminomatous Germ Cell Tumors: Hacettepe Experience
    Yalcin, B.
    Aydin, B.
    Tanyel, C.
    Orhan, D.
    Cemaloglu, M.
    Kurucu, N.
    Varan, A.
    Kutluk, T.
    Akyuz, C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S495 - S495
  • [40] Current management of stage I testicular non-seminomatous germ cell tumours
    Pectasides, D.
    Pectasides, E.
    Constantinidou, A.
    Aravantinos, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 70 (02) : 114 - 123